MOCKV SOLUTIONS INC.
Biotech · Acquired
Viral surrogate assay kits based on virus-like particles (VLPs) for predicting manufacturing clearance of Minute Virus of Mice (MVM) contamination
- Grants
- $800K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 3 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Demonstrating Utility of a Non-Infectious Minute Virus of Mice-Virus Like Particle for Predicting Viral Clearance during Biopharmaceutical Process Development | $250,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Demonstrating Utility of a Non-Infectious Minute Virus of Mice-Virus Like Particle for Predicting Viral Clearance during Biopharmaceutical Process Development | $250,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Demonstrating Feasibility of Producing a Highly Purified and Concentrated Stock Solution of Retrovirus Like Particles for Biopharmaceutical Process Development Viral Clearance Studies | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Demonstrating Feasibility of Producing a Highly Purified and Concentrated Stock Solution of Retrovirus Like Particles for Biopharmaceutical Process Development Viral Clearance Studies | $150,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2386 | RaeSedo, LLC | — | — |
| 2387 | Rakuten Medical, Inc. | — | $887M |
| 2388 | Avalo Therapeutics | — | $182M |
| 2389 | MOCKV SOLUTIONS INC. | — | — |
| 2390 | SERPIN PHARMA, LLC | — | — |
| 2391 | ZENO MANAGEMENT, INC | — | — |
| 2392 | CH3 BIOSYSTEMS, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods And Kits For Quantifying The Removal Of Mock Virus Particles From A Purified Solutiongranted
- Stock Solution Of Retrovirus Like Particles With Method And Kitapplication
- Methods And Kits For Quantifying The Removal Of Mock Virus Particles From A Purified Solutiongranted
- Stock Solution Of Retrovirus Like Particles With Method And Kitapplication
- Methods For Evaluating Viral Clearance From A Biopharmaceutical Solution Employing Mock Viral Particles.granted
- Stock Solution Of Retrovirus Like Particles With Method And Kitapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.